decitabine | |
---|---|
Trade Name | |
Orphan Indication | Chronic myeloid leukemia |
USA Market Approval | USA |
USA Designation Date | 1999-03-08 00:00:00 |
Sponsor | Otsuka Pharmaceutical Development &;Commercialization, Inc., 508 Carnegie Center Drive;Princeton, New Jersey, 08540 |
Related Access Program
Pusan National University Hospital – Chronic Myeloid Leukemia
University of California, San Francisco – Chronic Myeloid Leukemia
Emory University – Chronic Myeloid Leukemia
Pusan National University Hospital – Chronic myeloid leukemia
University of California, San Francisco – Chronic myeloid leukemia
Pfizer – Chronic myeloid leukemia
Emory University – Chronic myeloid leukemia